Eva Havrdová

Researcher Next ID · RN-009536

Researcher · Medicine

, Czechia

Not currently recruitingFunding unknown

Research interests

Medicine

Multiple Sclerosis Research Studies

Peripheral Neuropathies and Disorders

Polyomavirus and related diseases

Rheumatoid Arthritis Research and Therapies

Systemic Lupus Erythematosus Research

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
New England Journal of Medicine · 2012 · 10.1056/nejmoa1206328
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
The Lancet · 2012 · 10.1016/s0140-6736(12)61769-3
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
The Lancet · 2012 · 10.1016/s0140-6736(12)61768-1
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Annals of Neurology · 2011 · 10.1002/ana.22366
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
New England Journal of Medicine · 2006 · 10.1056/nejmoa044397

No projects listed.